Results 321 to 330 of about 418,657 (362)
Some of the next articles are maybe not open access.

Heart transplantation

2019
Heart transplantation remains the treatment of choice for end-stage heart failure refractory to conventional treatment. Long-term outcome is excellent, and median survival currently exceeds 13 years. The main causes of death late after transplantation are cardiac allograft vasculopathy and cancer.
Finn Gustafsson, Kasper Rossing
openaire   +1 more source

Pediatric heart transplantation

Paediatrics and Child Health, 2011
Abstract Paediatric heart transplantation is the last remaining treatment option for children in end-stage heart failure. Approximately 30 heart transplants are performed in the UK each year, between two specialist centres. Approximately two-thirds of recipients have suffered from a cardiomyopathy (mainly dilated), with the remainder mainly being ...
Jacob Simmonds, Michael Burch
openaire   +3 more sources

Heart Transplantation: A Review

Journal of Transplant Coordination, 1999
This article explores current developments and continuing dilemmas in heart transplantation. Statistical trends such as the increased number of candidates and the increased waiting time are described. Recent developments in implantable ventricular assist device technology and the perioperative use of nitric oxide are also highlighted.
openaire   +3 more sources

ECD for Heart Transplantation [PDF]

open access: possible, 2014
In October 1997, the Japanese Organ Transplant Act was issued and we needed to successfully start the first heart transplantation (HTx) in Japan. For this reason, very strict criteria for the donor heart were established by the task force committee for heart transplantation in the Ministry of Health, Labour and Welfare.
openaire   +2 more sources

Heart Transplantation in Perspective

Echocardiography, 1985
Abstract Heart disease remains one of the leading causes of death in the western world. In the 35 years since the first human heart transplants, cardiac transplantation has become established as the therapeutic option of choice in the management of terminal cardiac failure.
openaire   +4 more sources

A framework for developing sex-specific engineered heart models

Nature Reviews Materials, 2021
Sharon Fleischer   +2 more
exaly  

Heart Transplantation

Scandinavian Journal of Thoracic and Cardiovascular Surgery, 1970
openaire   +2 more sources

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors   +2 more
exaly  

Home - About - Disclaimer - Privacy